Baxter International Inc (BAX): Long-Term Debt

Annual figures by period end, from SEC filings.

$9.44B
As of 2025-12-31
-17.3%
3-year compound annual growth
+8.7%
5-year compound annual growth
$17.75B2020-12-31: $6.23B2021-12-31: $17.75B2022-12-31: $16.70B2023-12-31: $13.86B2024-12-31: $13.18B2025-12-31: $9.44B$9.44B
2020-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$9.44B-28.4%2026-02-12, Balance as of period end
2024-12-31$13.18B-4.9%2025-02-21, Balance as of period end
2023-12-31$13.86B-17.0%2024-02-08, Balance as of period end
2022-12-31$16.70B-5.9%2023-02-09, Balance as of period end
2021-12-31$17.75B+184.8%2022-02-23, Balance as of period end
2020-12-31$6.23Bn/a2021-02-11, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Baxter International Inc (BAX)2025-12-31$9.44B-28.4%
Solventum Corp (SOLV)2025-12-31$5.04B-37.1%
ResMed Inc (RMD)2026-06-30$399.42M-39.3%
3M Co (MMM)2025-12-31$12.60B-3.4%
West Pharmaceutical Services Inc (WST)2025-12-31$202.80M+0.1%
Teleflex Inc (TFX)2025-12-31$2.64B+59.5%
Integra Lifesciences Holdings Corp (IART)2025-12-31$726.56M-4.5%
Merit Medical Systems Inc (MMSI)2025-12-31$734.04M+0.6%
Haemonetics Corp (HAE)2026-03-28$1.24B-0.5%

Compare BAX, SOLV, RMD, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗